Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals

/PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) specialist developing next generation ADCs for a wide range of...

Related Keywords

London ,City Of ,United Kingdom ,Beijing ,China ,United States ,San Francisco ,California ,Shanghai ,Integrum Renmice ,Bertrand Damour ,Yuelei Shen ,Haimen Jiangsu ,Atlas Venture ,Biocytogen Pharmaceuticals Beijing Co ,Research Corporation Technologies ,Pheon Therapeutics ,Antibody Drug Conjugate ,Biocytogen Pharmaceuticals ,Chief Executive Officer ,Using Renmice ,Project Integrum ,Brandon Capital ,